A new Alzheimer’s drug has been rejected for widespread use in the health service in England after the health spending watchdog said it “does not currently demonstrate value for the NHS”. The news ...
Today, the Centre for Aging + Brain Health Innovation (CABHI), powered by Baycrest launched Ignite, its new funding program to support Canadian innovators designing solutions for older persons.